OBJECTIVES: Although community-acquired pneumonia (CAP) is one of the most common infections in children, no standardized risk classification exists to guide management. The objective of this study was to develop expert consensus for factors associated with various degrees of disease severity in pediatric CAP. METHODS: Using a web-based classical Delphi process, a multidisciplinary panel of 10 childhood pneumonia experts rated the degree of severity (mild, moderate, or severe) of clinical, radiographic, and laboratory factors, as well as outcomes relevant to pediatric pneumonia. Round 1 was open-ended, with panelists freely stating all characteristics they felt determined pneumonia severity. In rounds 2 to 4, panelists used a 9-point Likert scale (1-3, mild; 4-6, moderate; 7-9, severe) to rate severity for each item. Consensus was defined as 70% or greater agreement in ranking mild, moderate, or severe. RESULTS: Panelists identified 318 factors or outcomes in round 1; the panel reached consensus for 286 (90%). The majority of items without consensus straddled levels of severity (eg, mild-moderate). Notable clinical factors with consensus included age, oxygen saturation, age-based respiratory rate, and gestational age. Severity classification consensus was also reached for specific imaging and laboratory findings. Need for and duration of hospitalization, supplemental oxygen/respiratory support, and intravenous fluids/medications were considered important outcomes in classifying severity. CONCLUSIONS: This study presents factors deemed important for risk stratification in pediatric CAP by consensus of a multidisciplinary expert panel. This initial step toward identifying and formalizing severity criteria for CAP informs critical knowledge gaps and can be leveraged in future development of clinically meaningful risk stratification scores.
OBJECTIVES: Although community-acquired pneumonia (CAP) is one of the most common infections in children, no standardized risk classification exists to guide management. The objective of this study was to develop expert consensus for factors associated with various degrees of disease severity in pediatric CAP. METHODS: Using a web-based classical Delphi process, a multidisciplinary panel of 10 childhood pneumonia experts rated the degree of severity (mild, moderate, or severe) of clinical, radiographic, and laboratory factors, as well as outcomes relevant to pediatric pneumonia. Round 1 was open-ended, with panelists freely stating all characteristics they felt determined pneumonia severity. In rounds 2 to 4, panelists used a 9-point Likert scale (1-3, mild; 4-6, moderate; 7-9, severe) to rate severity for each item. Consensus was defined as 70% or greater agreement in ranking mild, moderate, or severe. RESULTS: Panelists identified 318 factors or outcomes in round 1; the panel reached consensus for 286 (90%). The majority of items without consensus straddled levels of severity (eg, mild-moderate). Notable clinical factors with consensus included age, oxygen saturation, age-based respiratory rate, and gestational age. Severity classification consensus was also reached for specific imaging and laboratory findings. Need for and duration of hospitalization, supplemental oxygen/respiratory support, and intravenous fluids/medications were considered important outcomes in classifying severity. CONCLUSIONS: This study presents factors deemed important for risk stratification in pediatric CAP by consensus of a multidisciplinary expert panel. This initial step toward identifying and formalizing severity criteria for CAP informs critical knowledge gaps and can be leveraged in future development of clinically meaningful risk stratification scores.
Authors: John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson Journal: Clin Infect Dis Date: 2011-08-31 Impact factor: 9.079
Authors: Derek J Williams; Matthew Hall; Jeffrey S Gerber; Mark I Neuman; Adam L Hersh; Thomas V Brogan; Kavita Parikh; Sanjay Mahant; Anne J Blaschke; Samir S Shah; Carlos G Grijalva Journal: Pediatrics Date: 2017-03-08 Impact factor: 7.124
Authors: Derek J Williams; Matthew Hall; Katherine A Auger; Joel S Tieder; Karen E Jerardi; Mary Ann Queen; Angela M Statile; Angela L Myers; Samir S Shah Journal: Pediatr Infect Dis J Date: 2015-07 Impact factor: 2.129
Authors: Thomas V Brogan; Matthew Hall; Derek J Williams; Mark I Neuman; Carlos G Grijalva; Reid W D Farris; Samir S Shah Journal: Pediatr Infect Dis J Date: 2012-10 Impact factor: 2.129
Authors: Shubhada Hooli; Tim Colbourn; Norman Lufesi; Anthony Costello; Bejoy Nambiar; Satid Thammasitboon; Charles Makwenda; Charles Mwansambo; Eric D McCollum; Carina King Journal: PLoS One Date: 2016-12-28 Impact factor: 3.240
Authors: Katherine E Gallagher; Maria D Knoll; Chrissy Prosperi; Henry C Baggett; W Abdullah Brooks; Daniel R Feikin; Laura L Hammitt; Stephen R C Howie; Karen L Kotloff; Orin S Levine; Shabir A Madhi; David R Murdoch; Katherine L O'Brien; Donald M Thea; Juliet O Awori; Vicky L Baillie; Bernard E Ebruke; Doli Goswami; Alice Kamau; Susan A Maloney; David P Moore; Lawrence Mwananyanda; Emmanuel O Olutunde; Phil Seidenberg; Seydou Sissoko; Mamadou Sylla; Somsak Thamthitiwat; Khalequ Zaman; J Anthony G Scott Journal: Clin Infect Dis Date: 2020-03-03 Impact factor: 9.079
Authors: Sunil Kumar Kasundriya; Mamta Dhaneria; Aditya Mathur; Ashish Pathak Journal: Int J Environ Res Public Health Date: 2020-06-27 Impact factor: 3.390
Authors: Todd Adam Florin; Daniel Joseph Tancredi; Lilliam Ambroggio; Franz E Babl; Stuart R Dalziel; Michelle Eckerle; Santiago Mintegi; Mark Neuman; Amy C Plint; Nathan Kuppermann Journal: BMJ Open Date: 2020-12-02 Impact factor: 2.692